The complexity of chronic kidney disease–mineral and bone disorder across stages of chronic kidney disease-Reference-Cited by-同舟云学术

The complexity of chronic kidney disease–mineral and bone disorder across stages of chronic kidney disease

Published:2017-06 Issue:6 Volume:91 Page:1436-1446
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Graciolli Fabiana G.,Neves Katia R.,Barreto Fellype,Barreto Daniela V.,dos Reis Luciene M.,Canziani Maria E.,Sabbagh Yves,Carvalho Aluizio B.,Jorgetti Vanda,Elias Rosilene M.,Schiavi Susan,Moysés Rosa M.A.

Publisher

Elsevier BV

Subject

Nephrology

Reference26 articles.

1. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD);Kidney Int Suppl,2009

2. Chronic kidney disease-mineral-bone disorder: a new paradigm;Moe;Adv Chronic Kidney Dis,2007

3. Repression of osteocyte Wnt/beta-catenin signaling is an early event in the progression of renal osteodystrophy;Sabbagh;J Bone Miner Res,2012

4. Mineral (Mal)adaptation to kidney disease–Young Investigator Award Address: American Society of Nephrology Kidney Week 2014;Wolf;Clin J Am Soc Nephrol,2015

5. Npt2b deletion attenuates hyperphosphatemia associated with CKD;Schiavi;J Am Soc Nephrol,2012

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cystinosis-Associated Metabolic Bone Disease Across Ages and CKD Stages 1 to 5D/T;The Journal of Clinical Endocrinology & Metabolism;2024-07-25

2. Sclerostin and Wnt Signaling in Idiopathic Juvenile Osteoporosis Using High-Resolution Confocal Microscopy for Three-Dimensional Analyses;Children;2024-07-04

3. A practical approach for anabolic treatment of bone fragility with romosozumab;Journal of Endocrinological Investigation;2024-05-24

4. The Molecular Mechanisms Underlying the Systemic Effects Mediated by Parathormone in the Context of Chronic Kidney Disease;Current Issues in Molecular Biology;2024-04-25

5. Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease;Current Opinion in Nephrology & Hypertension;2024-04-23